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Abstract
Background: Selenitetriglycerides are biologically active, organic forms of selenium formed as a result of the
modification of selenic acid and sunflower oil. Studies in rats have shown that they are well absorbed and of low
toxicity. There are no published studies on selenitetriglycerides supplementation in calves.
Results: In this study, selenitetriglycerides were administered once orally on the 2nd day of life at a dose of 0.5 or
1 mg Se/kg body weight to each of six Holstein-Friesian calves while six control calves were not supplemented.
Blood for determination of selenium concentration, glutathione peroxidase activity, haematological parameters,
aspartate aminotransferase, creatine kinase, and lactate dehydrogenase activities and glucose, total protein, albumin,
triglycerides, cholesterol, urea, and creatinine concentration was collected before supplementation (day 0) and 1, 2,
5, 10 and 14 days after supplementation. Selenitetriglycerides administration increased (P < 0.01) serum selenium
concentration in supplemented calves as early as day1, from a mean of 63.4 to 184.22 μg/l in calves receiving
selenium at a dose of 0.5 mg/kg BW, and from 63.17 to 200.33 μg/l in calves receiving 1 mg/kg. Serum selenium
concentrations remained significantly higher compared to the control group throughout the experiment.
Glutathione peroxidase activity was higher in supplemented than control calves, significantly so in animals receiving
the 1 mg/kg dose of Se on the 10th and 14th days (P < 0.05). There were no significant differences in the
haematological and biochemical parameters between the groups.
Conclusions: This experiment showed that supplementation with selenitetriglycerides could significantly improve
blood selenium status in calves without adverse effects on haematological or biochemical parameters. These
findings are essential prerequisites for future studies on selenitetriglycerides supplementation to manage clinical
selenium deficiency in calves.
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Background
Selenium (Se) has diverse biological roles ranging from
participation in antioxidant and detoxification processes,
through stimulating the proliferation of B cells and the
production of IgM and IgG, to antiviral, antibacterial,
and anticancer properties [1–3]. Nutritional muscular
dystrophy (NMD), also known as white muscle disease,
is the most common clinical disorder caused by selen-
ium deficiency in cattle. Young animals with hyposele-
nosis are also more susceptible to respiratory and
gastro-intestinal infections. Additionally, reduced weight
gains have been reported in selenium-deficient cattle [4].
The prevalence of clinical selenium deficiency varies
widely internationally. It is more commonly observed in
pasture-based systems depending on the type of bed-
rock, pasture selenium content and whether effective sel-
enium supplementation is practiced. Clinical selenium
deficiency is less commonly seen in confinement systems
where adequately balanced partial (PMR) or total mixed
ration (TMR) is fed. Newborn calves should have ad-
equate selenium reserves if the pregnant dam was fed
sufficient selenium as the element crosses the placenta.
However, where gestational selenium supplementation is
inadequate, the newborn calf may be born selenium-
deficient [5], and supplementation with this nutrient is
required.
Selenitetriglycerides are biologically active, organic
forms of selenium in the + 4-oxidation state formed as a
result of the modification of selenic acid and sunflower
oil. Studies in rats have shown that they are well
absorbed after oral, subcutaneous, and intraperitoneal
administration. After the absorption of selenium in sele-
nitetriglycerides from the gastrointestinal tract, it is
bound by erythrocytes and serum albumin and globulin
and transported to tissues [6]. Organic forms of Se have
lower toxicity than inorganic forms, specifically, selenite-
triglycerides have been shown to have very low toxicity
in rats [6].
Due to the presence of many chemical forms of this
metalloid, which have different biological properties, in-
cluding toxicity, the effect of supplementation with sele-
nitetriglycerides may differ between species. For
example, while research by Sochocka et al. [7] in healthy
Swiss mice showed an increase in the activity of the sele-
noenzyme glutathione peroxidase (GSH-Px) following
selenitetriglycerides administration which was confirmed
after selenitetriglycerides administration in people with
prostate cancer [8], this response was not found in re-
search conducted on sheep [9]. To date, there have been
no equivalent studies in calves.
Given the proven biological activity of selenitetrigly-
cerides in other species, the lack of data in cattle and the
potential benefits of such activity in young stock, it was
decided to evaluate selenitetriglycerides use in calves. It
was hypothesised based partly on studies in other species
that a single administration of selenitetriglycerides would
increase serum Se concentration and, consequently,
blood GSH-Px activity and alter selected haematological
and biochemical blood parameters. This study is an es-
sential step to take before evaluating the clinical efficacy
of this form of Se in cases of suspected Se deficiency.
Materials and methods
Animals, diets, and experimental design
The research was conducted on 18 Holstein-Friesian fe-
male calves from one farm located in north-eastern
Poland. The experimental calves were randomly selected
at one day of age. The calves were from cows in second
and third lactation. The cows were housed all year
round in a freestall barn and fed a partial mixed ration
(PMR) supplemented with a vitamin and mineral premix
(9 mg selenium/animal/day) and concentrate at 4 kg/
animal throughout the dry period. The animals were
randomly allocated to one of three equal (n = 6) experi-
mental groups; an unsupplemented control group and
two supplemented groups which received selenitetrigly-
cerides at two days of age in a single oral dose of 0.5 and
1 mg Se/kg BW, respectively. These dose rates were
chosen based on limited previous experimental studies
in rats [6] and sheep [9]. The liquid preparation was ad-
ministered using a calibrated oral drencher in the morn-
ing. The calves were fed 2.5 l of the mother’s colostrum
administered by stomach tube 2 h after birth, and an-
other 2 l of the same colostrum 6 h after birth. After a
5-day colostrum period, the seven day old calves re-
ceived 6–8 l of their own dam’s milk using a teated-
bucket, twice a day, and a starter feed in the form of
crunch/loose mix from 8 day of life. This feed consisted
of micronized corn, soybean meal (non-GMO), micron-
ized barley, wheat gluten, micronized wheat, rapeseed
meal, beet molasses, dried alfalfa, calcium carbonate, so-
dium chloride, monocalcium phosphate, and fodder
yeast. The animals were kept in conditions meeting the
requirements for farm animals’ welfare in individual
pens bedded with straw and had unlimited access to
water and hay.
Sampling and analyses
Blood was collected by venepuncture from the external
jugular vein of each calf six times into tubes containing
a clot activator (9 ml, Vacuette, Greiner Bio-One,
France) for serum analyses of selenium and biochemical
parameters, into vacutainers containing K2 EDTA (4 ml,
Vacuette, Greiner Bio-One, France) for hematological
analysis and into tubes containing lithium heparin (6 ml,
Vacuette, Greiner Bio-One, France) for determination of
glutathione peroxidase. Samples taken for selenium esti-
mation were stored at -22 C for further determination,
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the other analyses were conduced withing 4 h after sam-
pling. The first sample was collected on the day of, but
before, Se administration (day 0), and subsequent sam-
ples were collected 1, 2, 5, 10, and 14 days a.m. after Se
administration. Serum Se concentration was determined
by hydride generation-flame atomic absorption spec-
trometry (Unicam 939 Solar Spectrophotometer). The
activity of GSH-Px was measured in whole blood by the
kinetic method using cumene hydroxide and phosphate
buffer in an Epoll 20 analyzer using the Ransel diagnos-
tic kit (Randox Laboratories, Crumlin, UK). The follow-
ing haematological parameters were determined in
whole blood samples: white blood cell count (WBC), red
blood cell count (RBC), hemoglobin concentration
(HGB), hematocrit (HCT), mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC) and
platelet count (PLT) (flow cytometry based on laser light
scatter) (ADVIA 2120, Siemens Healthcare Diagnostics,
Tarrytown, USA). The following biochemical parameters
were determined: activity of aspartate aminotransferase
(AST), creatine kinase (CK), lactate dehydrogenase
(LDH) and the concentrations of triglycerides (TG),
cholesterol (CHOL), glucose (GLU), total protein (TP),
albumin (ALB), urea (UREA) and creatinine (CREA)
(Cormay ACCENT 200 Automatic Biochemical Analyzer
and Cormay diagnostic kits, Lomianki, Poland).
Statistical analysis
The normality of parameters distribution and their
homogeneity of variance were tested using the Shapiro-
Wilk and Levene’s tests, respectively. As none of the
data followed a normal distribution, the Kruskall – Wal-
lis test followed by Mann-Whitney U tests with adjust-
ment for multiple comparisons were used for group
comparisons at each sampling point. Changes over time
were tested using repeated measures Friedman ANOVA.
Data are presented as mean ± sem and mean-fold
change. Two levels of significance were adopted: * p <
0.05 and ** p < 0.01.
Results
The concentration of serum Se increased after supple-
mentation 2.9-fold (from 63.4 ± 1.84 µg/l on day 0 to
184.22 ± 13.73 µg/l on day 1) and 3.17-fold (from
63.17 ± 1.72 µg/l on day 0 to 200.33 ± 21.42 µg/l on day
1) in the 0.5 mg/kg (P < 0.01) and 1 mg/kg (P < 0.01)
groups, respectively, while in the control group concen-
trations gradually decreased over time (from 65.43 ±
1.63 µg/l on day 0 to 56.97 ± 1.23 µg/l on day 14, P <
0.01). Selenium concentrations were higher throughout
the experiment (after day 0) in the supplemented groups
compared to the control group (P < 0.05). In addition, Se
concentrations were higher in the 1 mg/kg group
compared to the 0.5 mg/kg group from the fifth (1.36-
fold, P < 0.05) to the 14th day (1.14-fold, P < 0.05) (Fig. 1).
Over time, GSH-Px activity decreased (from 204.4 ±
14.39 IU/gHb on day 0 to 131.47 ± 12.97 IU/gHb on day
14, P < 0.01) in the control group while it increased in
the 1 mg/kg group (from 199.83 ± 11.38 IU/gHb on day
0 to 216.53 ± 27.52 IU/gHb on day 14, P < 0.05). GSH-
Pxwas higher in the 1 mg/kg group compared to the
control group on day 10 (1.48-fold, 221.06 ± 15.39 IU/
gHb vs. 149.18 ± 7.72 IU/gHb, P < 0.05) and day 14
(1.65-fold, 216.53 ± 27.52 IU/gHb vs. 131.47 ± 12.97 IU/
gHb, P < 0.05) (Fig. 2).
There were no significant differences in any of the
haematological parameters between the groups of calves,
except on day 14, when the MCV of control calves was,
on average, higher than that of the 0.5 mg group, though
the absolute difference was small (1.45 pg) (Table 1).
Over time, there was a significant decrease in MCV and
a significant increase in the number of platelets; the
other parameters did not change significantly (Table 1).
Significant differences between groups in the concentra-
tion of cholesterol (day10; control higher than 0.5 mg),
in urea level (day 1; 1 mg higher than 0.5 mg) and in
creatinine level (day 0; 1 mg higher than 0.5 mg) were
observed. However, values remained within the physio-
logical limits. There were no significant differences in
any group of the calves’ in other biochemical parameters
and no changes over time in all parameters (Table 2).
Discussion
This is the first study to investigate the effects of seleni-
tetriglycerides in calves. Such basic studies on the bio-
logical activity of these products are needed before
studies on clinical efficacy to determine whether toxicity
is an issue and whether they produce changes in selen-
ium status and related haematological and biochemical
parameters beneficial in managing clinical Se deficiency.
The present study showed a rapid increase in the
serum Se concentration after a single oral dose of seleni-
tetriglycerides in calves. Selenium concentration in-
creased more than three-fold in both supplemented
groups within 24 h, the increase being higher at the
1 mg/kg dose. This supports the hypothesis that using a
form with contains more selenium has excellent bio-
availability after per os administration in unweaned
calves. Though comparable studies with this form of
Se are not available in calves, previous studies using a
single intramuscular injection of sodium selenite
(0.1 mg/kg BW) increased serum Se concentration
three days after supplementation in calves [10], while
dietary sodium selenite supplementation (100 mg/
cow/day, cir. 0.17 mg/kg BW) increased cows serum
Se within two to six days [11].
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In addition to this rapid increase in serum Se concen-
tration, a single oral dose of selenitetriglycerides main-
tained serum Se concentrations above those in the
control group and above baseline concentrations
throughout the experimental period (14 days). These re-
sults differ from those obtained in serum and liver Se
concentrations following a single oral dose of selenium
in cattle, where such changes were not observed [12].
Studies performed by Pavlata et al. [13] showed an in-
crease in selenium in the blood of calves (from 70.25 to
127.5 µg/l) after the daily oral administration of selen-
ium yeast (0.6 mg/kg BW) for two months. The single
selenitetriglycerides oral doses used in the present study
resulted in a larger increase in selenium concentration
than the cited studies, albeit for a shorter period. This
response in calves confirms the results of previous re-
search performed in dairy cows, which showed a large
increase in serum selenium concentration (from
64.92 µg/l to 127.95 µg/l) on the second day after oral
administration of selenitetriglycerides [14].
In contrast to the supplemented calves in the present
study, serum Se concentrations declined significantly in
control calves over time. By the end of the experiment
(day 14) the mean serum Se concentration in the control
group (56 µg/l) was below the normal range for calves
[15]. This decline in serum Se concentration reflected
the inadequacy of the Se content/bioavailability of the
whole milk and starter feed intake to maintain calf Se
status as Se requirements increase with calf growth.
Oral dosing of calves with 1 mg/kg BW of Se resulted
in a significant increase in GSH-Px activity between day
0 and day 10. There was also a numeric increase in
GSH-Px activity on day 5 in calves administered 0.5 mg/
kg BW of Se. These findings indicate that the higher
dose is required to improve Se status for longer. Numer-
ous studies confirm response lagging GSH-Px activity
Fig. 1 Serum selenium concentration (ug/l) in supplemented and un-supplemented calves (mean + sem). **- P < 0.01: Representing the
significance of change over time in selenium serum concentration in each studied group (Friedmans ANOVA). Different letters (A, B, C) represent
the significant difference (P < 0.05) in concentration between groups at each sampling date
Fig. 2 The activity of glutathione peroxidase in supplemented and un-supplemented calves (mean + sem). ns- P > 0.05, *- P < 0.05, **- P < 0.01:
Representing the significance of change over time in glutathione peroxidase activity in each studied group (Friedmans ANOVA). Different letters
(A, B) represent the significant difference (P < 0.05) in glutathione peroxidase activity between groups at each sampling date
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(approx. 10–12 days) after Se administration [10, 16, 17].
According to Philipoo et al. [18], the time that elapses
from selenium supplementation to the increase in GSH-
Px activity results from the fact that selenium is first
used to replenish tissue reserves and only then to
synthesize peroxidase. On the other hand, Arthur [19]
explained this period by the mechanisms of selenium in-
corporation into erythrocytes during erythropoiesis and
the time necessary for the biosynthesis of the enzyme it-
self. It should be noted that during the monitoring period
of this study (0–14 days of age) foetal erythrocytes com-
prised the majority of the calves’ red cell population, being
replaced by adult erythrocytes by eight to 13 weeks of age
[20]. Though it should be recognised that this conversion
from foetal to adult haemoglobin is a dynamic process
which would have already commenced during the moni-
tored response period of the study.
The increase in GSH-Px activity found here after
selenitetriglycerides administration is congruent with
findings from studies conducted in humans [8] and
mice [7] but conflicts with results from studies in
sheep. There was no increase in plasma glutathione
peroxidase, cytosolic glutathione peroxidase, type I
and type II iodothyronine deiodinases and thioredoxin
reductase in the brain, adrenal glands, kidneys, liver
and thyroid of sheep supplemented orally with 60 mg
(cir. 1.2 mg/kg BW) of selenitetriglycerides per animal
per day for a month [9]. The activity of plasma GSH-
Px increased insignificantly up to the 10th day of the
experiment (from 67.0 U/l to 115.6 U/l), but by the
14th day of the experiment, it significantly decreased
(to 54.1 U/l) and continued to decline until the end
of the experiment. Similarly, no significant increase in
GSH-Px activity in whole blood was observed during
28 days of oral selenitetriglycerides supplementation
in sheep [9]. Though whole blood GSH-Px is a lag
phase indicator of improved selenium status (com-
pared to blood selenium concentration), given that
neither plasma GSH-Px (rapid bioindicator of im-
proved selenium status) nor whole blood GSH-Px
Table 1 Hematological parameters (mean + sem) in calves
Group N 0 1 2 5 10 14
WBC
(109/L)
control 6 6.38 ± 0.51 7.11 ± 0.54 7.05 ± 0.65 6.35 ± 0.82 7.19 ± 0.43 6.13 ± 0.35
0.5 mg/kg 6 6.38 ± 0.85 6.42 ± 0.97 6.07 ± 0.99 7.85 ± 0.73 6.85 ± 0.63 6.84 ± 0.74
1 mg/kg 6 6.55 ± 0.43 6.8 ± 0.92 6.53 ± 0.8 7.03 ± 0.88 7.31 ± 0.54 6.76 ± 0.64
RBC
(10¹²/L)
control 6 7.63 ± 0.6 7.47 ± 0.5 7.35 ± 0.63 7.61 ± 0.45 7.01 ± 0.39 6.99 ± 0.58
0.5 mg/kg 6 7.23 ± 0.47 7.02 ± 0.32 7.68 ± 0.69 7.69 ± 0.69 7.57 ± 0.6 7.61 ± 0.54
1 mg/kg 6 7.81 ± 0.5 7.39 ± 0.41 7.6 ± 0.32 8.46 ± 0.63 8 ± 0.43 8.02 ± 0.51
HGB
(g/dL)
Control 6 8.73 ± 0.61 8.95 ± 0.97 9.07 ± 0.95 7.57 ± 1 8.67 ± 0.86 8.97 ± 0.87
0.5 mg/kg 6 7.72 ± 0.75 7.65 ± 0.77 8.12 ± 1.06 7.85 ± 1.02 7.25 ± 0.9 7.43 ± 0.97
1 mg/kg 6 8.93 ± 0.71 8.33 ± 0.6 8.5 ± 0.51 9.45 ± 0.91 8.6 ± 0.67 8.55 ± 0.88
HCT
(L/L)
control 6 32.08 ± 1.75 31.37 ± 1.04 31.2 ± 0.83 31.62 ± 0.95 32.43 ± 1.56 32.52 ± 1.85
0.5 mg/kg 6 28.62 ± 2.47 27.73 ± 1.93 30.23 ± 3.55 29.72 ± 3.48 27.45 ± 3.24 27.2 ± 3.32
1 mg/kg 6 32.67 ± 2.51 30.7 ± 2.19 31.28 ± 1.83 35.83 ± 3.65 32.13 ± 2.39 30.37 ± 2.64
MCV
(fL)
Control** 6 38.9 ± 1.19 37.17 ± 1.1 35.37 ± 1.35 36.87 ± 1.1 35.13 ± 1.14 34.02 ± 1.29
0.5 mg/kg* 6 39.33 ± 1.33 39.35 ± 1.34 39.98 ± 1.38 37.22 ± 1.34 36 ± 1.65 35.08 ± 1.89
1 mg/kg** 6 40.73 ± 1.01 40.38 ± 0.95 40.05 ± 0.9 39 ± 1.22 39.72 ± 0.87 37.63 ± 1.15
MCH
(pg)
control 6 12.07 ± 0.68 11.73 ± 0.65 11.65 ± 0.67 11.58 ± 0.52 11.38 ± 0.44 11 ± 0.47 A
0.5 mg/kg 6 10.57 ± 0.43 10.77 ± 0.68 10.42 ± 0.51 10.05 ± 0.48 10.57 ± 0.5 9.55 ± 0.61B
1 mg/kg 6 11.38 ± 0.36 11.22 ± 0.34 11.12 ± 0.31 11.1 ± 0.31 11.23 ± 0.28 10.57 ± 0.55AB
MCHC
(g/dL)
control 6 27.18 ± 0.29 27.93 ± 0.69 27.45 ± 0.45 27.25 ± 0.58 27.05 ± 0.38 26.97 ± 0.7
0.5 mg/kg 6 26.88 ± 0.29 27.27 ± 0.94 26.65 ± 0.42 26.22 ± 0.39 26.7 ± 0.29 27.13 ± 0.49
1 mg/kg 6 27.32 ± 0.41 27.1 ± 0.41 27.08 ± 0.34 26.42 ± 0.24 26.97 ± 0.23 28 ± 0.69
PLT
(109/L)
Control* 6 533.17 ± 69.4 653 ± 74.43 840.83 ± 42.06 826.83 ± 68.33 851.5 ± 50.76 737.17 ± 34.63
0.5 mg/kg* 6 537.17 ± 51.05 672.83 ± 45.89 888.17 ± 40.02 775 ± 100.1 718 ± 86.31 685.67 ± 77.2
1 mg/kg* 6 464.5 ± 51.75 595.33 ± 71.16 744.5 ± 81.31 707.67 ± 93.61 790 ± 63.31 692.17 ± 68.17
Hematological parameters in calves either supplemented with selenitetriglycerides or not supplemented (control) on day 0 (before supplementation) and days 1–
14 after supplementation. *- P < 0.05, **- P < 0.01: Representing the significance of change over time in studied parameters in each studied group (Friedmans
ANOVA). Different letters (A, B) represent the significant difference (P < 0.05) in concentration between groups in each sampling date
Żarczyńska et al. Irish Veterinary Journal           (2021) 74:11 Page 5 of 9
increased significantly over a month indicates that
while the response period was adequate [allowing for
erythropoiesis (< 7d)], another factor must account for
the non-responsive GSH-Px activity. Differences in
GSH-Px activity observed between our result and re-
sults obtained by these authors may be related to the
fact that the described studies were carried out on
adult sheep with a fully developed rumen, which
could interfere with the absorption of orally adminis-
tered selenium. In contrast to the supplemented
calves, GSH-Px activity declined significantly in con-
trol calves, which was also, as expected, correlated
with a significant decrease in serum Se.
In both doses, the administration of selenitetriglycer-
ides did not significantly influence the red cell indices,
the number of white blood cells, or platelets in calves.
Similar results were obtained for the number of RBC
and HGB concentration in calves receiving Se in the
form of sodium selenate by Shinde et al. [21]. Also, an
earlier study by Bednarek et al. [22] found no effect of
selenium (and vitamin E) administration on RBC count
and HGB concentration in calves. However, administra-
tion of Se in the form of sodium selenite at dose of
2.5 mg/kg for 21 days and 0.25 mg/kg for 16 weeks
induced acute and chronic selenosis in calves with
significant decreased of total number of RBC and
Table 2 Biochemical parameters (mean + sem) in calves
Group 0 1 2 5 10 14
AST
(U/l)
control 58.83 ± 2.8 59 ± 2.42 56.67 ± 2.38 56.17 ± 2.4 56.33 ± 2.51 55 ± 3.28
0.5 mg/kg 60.17 ± 3.75 51 ± 7.13 56 ± 4.5 57.83 ± 0.4 56.17 ± 1.54 55.5 ± 2.58
1 mg/kg 61.83 ± 3.83 57.5 ± 0.5 54.17 ± 2.46 60.5 ± 0.99 62.5 ± 4.72 55.17 ± 2.83
LDH
(U/l)
control 1159.83 ± 66.26 1217.33 ± 90.77 1148.5 ± 58.26 1140 ± 75.18 1165.17 ± 71.55 1117.33 ± 75.07
0.5 mg/kg 1154.83 ± 95.05 1108.67 ± 93.88 1110.5 ± 107.98 1017.83 ± 85.1 1048.5 ± 71.01 1168.33 ± 97.59
1 mg/kg 1180.67 ± 24.07 1226.67 ± 34.88 1157.67 ± 34.42 1093 ± 65.04 1179.5 ± 132.76 1291.33 ± 76.73
CK
(U/l)
Control 88.43 ± 11.96 94.27 ± 9.57 113.65 ± 16.11 100.42 ± 8.41 143.48 ± 10.7 122.33 ± 11.37
0.5 mg/kg 107.12 ± 29.22 182.13 ± 86.75 131.73 ± 25.42 100.2 ± 9.7 184.9 ± 34.76 149.78 ± 12.96
1 mg/kg 103.28 ± 17.96 79.33 ± 13.38 98.77 ± 24.75 99.82 ± 14.27 127.03 ± 6.45 169.37 ± 22.36
TG
(mmol/l)
control 0.18 ± 0.03 0.25 ± 0.03 0.24 ± 0.03 0.23 ± 0.03 0.15 ± 0.01 0.22 ± 0.02
0.5 mg/kg 0.16 ± 0.02 0.19 ± 0.02 0.24 ± 0.03 0.18 ± 0.04 0.2 ± 0.03 0.2 ± 0.03
1 mg/kg 0.42 ± 0.28 0.2 ± 0.04 0.26 ± 0.04 0.24 ± 0.02 0.16 ± 0.02 0.23 ± 0.04
Chol
(mmol/l)
control 1.66 ± 0.15 1.9 ± 0.09 1.76 ± 0.06 1.42 ± 0.1 2.12 ± 0.11 A 2 ± 0.17
0.5 mg/kg 1.9 ± 0.2 1.88 ± 0.17 1.83 ± 0.1 1.55 ± 0.13 1.67 ± 0.17B 1.97 ± 0.27
1 mg/kg 1.54 ± 0.09 1.55 ± 0.15 1.71 ± 0.17 1.78 ± 0.12 1.78 ± 0.12AB 1.72 ± 0.23
Gluc
(mmol/l)
control 6.21 ± 0.24 6.3 ± 0.35 5.91 ± 0.29 6.07 ± 0.33 5.96 ± 0.29 5.72 ± 0.29
0.5 mg/kg 5.79 ± 0.41 6.55 ± 0.46 5.73 ± 0.06 5.68 ± 0.29 5.26 ± 0.3 5.39 ± 0.22
1 mg/kg 6.79 ± 0.25 6.93 ± 0.52 6.64 ± 0.3 6.26 ± 0.32 5.28 ± 0.41 5.58 ± 0.35
ALB
(g/l)
control 32.87 ± 0.93 33.5 ± 0.82 34.55 ± 0.98 34.73 ± 1.41 33.8 ± 0.74 34.57 ± 0.96
0.5 mg/kg 31.63 ± 0.63 31.02 ± 0.63 32.03 ± 0.96 32.13 ± 1.09 32.35 ± 0.61 33.02 ± 0.7
1 mg/kg 32.55 ± 1.16 33.45 ± 0.66 33.47 ± 0.51 33.83 ± 1.01 33.72 ± 0.96 35.33 ± 0.67
TP
(g/l)
control 55.73 ± 1.91 48.1 ± 8.5 56.95 ± 1.47 55.75 ± 1.96 53.28 ± 2.34 51.9 ± 1.66
0.5 mg/kg 56.05 ± 1.22 53.07 ± 1.43 55.05 ± 2.22 51.23 ± 2.17 48.63 ± 1.08 49.22 ± 1.71
1 mg/kg 56.77 ± 2.32 55.02 ± 1.73 55.12 ± 1.65 56.8 ± 1.85 51.52 ± 2.07 51.68 ± 2.01
Urea
(mmol/l)
control 4.28 ± 0.47 4.15 ± 0.46AB 4.26 ± 0.45 4.51 ± 0.18 4.52 ± 0.36 4.51 ± 0.34
0.5 mg/kg 3.98 ± 0.37 3.95 ± 0.21 A 4.25 ± 0.25 4.87 ± 0.34 4.6 ± 0.46 3.79 ± 0.51
1 mg/kg 4.8 ± 0.48 4.58 ± 0.58B 4.71 ± 0.28 6.8 ± 1.87 5.27 ± 0.25 4.27 ± 0.43
Crea
(μmol/l)
control 83.32 ± 4.12AB 89.9 ± 4.08 90.28 ± 8.14 91.08 ± 5.85 93.58 ± 8.02 94.85 ± 11.69
0.5 mg/kg 77.52 ± 2.61 A 80.5 ± 3.18 84.5 ± 5.43 87.05 ± 5.03 84.9 ± 4.29 90.52 ± 6.15
1 mg/kg 90.68 ± 3.3B 92.13 ± 1.87 96.42 ± 3.45 133.62 ± 29.65 100.6 ± 4.53 92.5 ± 3.35
The activity of aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), and serum concentrations of glucose (Gluc), total protein (TP),
albumin (ALB), triglycerides (TG), cholesterol (Chol), urea (Urea), creatinine (Crea) in calves either supplemented with selenitetriglycerides at two doses 0.5 or
1.0 mg/kg or not supplemented (control) on day 0 (before supplementation) and days 1–14 after supplementation. Different letters (A, B) represent the significant
difference (P < 0.05) in concentration between groups in each sampling date
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WBC as well as HGB concentration [23]. Some age-
related physiological changes in the haemogram were
observed in the present study, similarly to data ob-
tained by other authors [20]. The reduction in RBC
volume observed is related to the maturation of blood
cells as the calves get older [24, 25]. The number of
PLT increased significantly throughout the experiment
in both control and experimental groups. Platelet
count increases rapidly in the first days of a calf’s life
[24, 26]. For example, Egli and Blum [27] showed a
sharp increase in the number of PLT in calves, from
the first to the seventh day of their life, which hardly
changed until the 84th day.
In summary supplementation with selenitetriglycerides
did not influence hematological parameters in calves,
only physiological fluctuations in the values of these
indcators were observed.
Supplementation with selenitetriglycerides, at either
dose, had no significant effect on the biochemical indices
monitored in this study. The glucose results were within
the reference range for calves [28]. Inorganic Se supple-
mentation similarly did not affect calves’ blood glucose
concentration [21] or in adult cattle [29]. Despite this
experimental evidence, theoretically, there is a hypothe-
sized effect of Se on glucose metabolism; studies in rats
and human revealed that Se might stimulate glucose in-
take and regulation of metabolic processes such as gly-
colysis, gluconeogenesis, fatty acid synthesis, or the
pentose phosphate pathway [30].
The lack of an effect of Se supplementation on total
protein and albumin concentrations in the present study
confirms the findings of Shinde et al. [21] in calves.
However, a study in goats showed that selenium might
stimulate protein biosynthesis, and Se supplementation
may increase this blood total protein concentration in
ruminants, but such effects were observed during much
longer studies – after 160 days of oral supplementation
of selenium [31].
While both the results of the present study and those
of Singh et al. [32] found no effect of Se supplementa-
tion on blood total cholesterol concentration in calves,
Shinde et al. [21] found that Se administration increased
the concentration of total cholesterol and its HDL
(High-density lipoprotein) fraction in calves. The authors
explained this observation by the positive effect of in-
creased blood selenium concentration on pancreatic
function, which facilitated the absorption and digestion
of dietary fat. The failure of Se supplementation to alter
physiologically normal serum triglyceride concentrations
in the present study confirms previous findings on Se
supplementation in calves [21, 33].
An increase in liver enzymes activity, especially AST,
is a sensitive indicator of potential selenium poisoning in
ruminants [34]. Hence, it may be inferred from Se
supplementation’s failure to alter the activity of liver en-
zymes (AST and LDH) in the present study that seleni-
tetriglycerides, used at these doses did not adversely
affect liver function. A similar finding was reported
following supplementation of cows with sodium selenate
at a dose of 100 mg per animal for 28 days [11]. How-
ever, calves are more sensitive to selenium poisoning.
Daily supplementation of calves with sodium selenate at
0.25 mg/kg BW resulted in the clinical signs of sub-
chronic selenosis after 12 weeks of administration, when
blood selenium concentration exceeded 1680 µg/l. [35].
In an experimental study with buffalo calves, adverse
effects appeared when the whole blood selenium con-
centrations increased above 2000 µg/l, with mortality
occurring when blood levels exceeded 3400 µg/l [36].
The maximum concentration of serum selenium in the
present study was 200 µg/l, well below the values associ-
ated with clinical toxicity.
While CK is one of the most sensitive and fastest indi-
cators of changes occurring in the course of NMD in
calves [37], in the absence of NMD in the present study,
it is not surprising that the presence or absence of Se
supplementation did not alter blood CK activity.
The lack of consistent effects of Se supplementation,
at the doses used here, on the serum concentrations of
urea and creatinine indicates that there was no adverse
effect on renal function of a single selenitetriglycerides
administration. Similarly, changes in the concentration
of urea and creatinine were not observed by Mudgal
et al. [38] and Shinde et al. [21] in calves receiving so-
dium selenate at a dose of 0.3 mg/kg dry matter and by
Singh et al. [32] who induced selenosis by ad lib. feeding
of selenium enriched (8.54 ppm) wheat straw for three
months. In summary, supplementation with selenitetri-
glycerides, at either dose, had no significant effect on the
biochemical indices monitored in this study. There was
no effect of supplementation on glucose concentrations,
indicators of protein and fat metabolism, liver enzymes
and kidney function. Regarding the study limitations, the
product used is not currently commercially available. To
confirm these preliminary findings, research should be
conducted on a larger group of animals and in order to
broaden our understanding of the dose-response rela-
tionship, use at least three different doses. In addition,
studies should be conducted in beef calves and calves
should be monitored for a longer period.
Conclusions
This experiment showed that oral administration of sele-
nitetriglycerides, at either 0.5 or 1 mg/kg BW, is an ef-
fective and safe form of selenium supplementation in
calves. A single administration of 0.5 and 1 mg/kg BW
of selenitetriglycerides significantly increased serum sel-
enium concentration for 14 days. The obtained results
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showed that the higher dose of selenitetriglycerides is
safe and more effective in improving Se status and the
monitored biochemical parameters indicate that the sup-
plementation did not have a negative effect on the func-
tioning of the liver and kidneys. Given these results, it is
concluded that selenitetriglycerides are safe to use in
further research on their role in managing clinical Se de-
ficiency/NMD in calves.
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